combined oxidative phosphorylation defect type 30

Summary

combined oxidative phosphorylation defect type 30 is a developmental defect during embryogenesis^[1]. It is known by 4 alternative names across languages and contexts.^[2]

Key Facts

• combined oxidative phosphorylation defect type 30's instance of is recorded as developmental defect during embryogenesis^[3].
• combined oxidative phosphorylation defect type 30's instance of is recorded as rare disease^[4].
• combined oxidative phosphorylation defect type 30's instance of is recorded as class of disease^[5].
• combined oxidative phosphorylation defect type 30 is a type of rare genetic developmental defect during embryogenesis^[6].
• combined oxidative phosphorylation defect type 30 is a type of neurometabolic disease^[7].
• combined oxidative phosphorylation defect type 30 is a type of combined oxidative phosphorylation deficiency^[8].
• combined oxidative phosphorylation defect type 30 is a type of autosomal recessive disease^[9].
• combined oxidative phosphorylation defect type 30's genetic association is recorded as TRMT10C^[10].
• combined oxidative phosphorylation defect type 30's exact match is recorded as http://www.orpha.net/ORDO/Orphanet_478042^[11].
• combined oxidative phosphorylation defect type 30's exact match is recorded as http://purl.obolibrary.org/obo/DOID_0111471^[12].
• combined oxidative phosphorylation defect type 30's exact match is recorded as http://identifiers.org/doid/DOID:0111471^[13].

Why It Matters

combined oxidative phosphorylation defect type 30 is known by 4 alternative names across languages and contexts.^[2]